Market Tracker

10/24 6:05pm ET

Incyte Corp (NASDAQ:INCY)

55.07
Data as of Oct 24
 +0.12 / +0.22%
Today’s Change
35.21
Today|||52-Week Range
70.86
+8.77%
Year-to-Date
No recent news for Incyte Corp.

Today’s Trading

Previous close54.95
Today’s open55.00
Day’s range53.76 - 55.93
Volume1,258,331
Average volume (3 months)958,689
Market cap$9.3B
Dividend yield--
Data as of 3:59pm ET, 10/24/2014

Growth & Valuation

Earnings growth (last year)-64.71%
Earnings growth (this year)+36.05%
Earnings growth (next 5 years)+83.94%
Revenue growth (last year)+19.49%
P/E ratioNM
Price/Sales21.17
Price/Book--

Competitors

 Today’s
change
Today’s
% change
PCYCPharmacyclics Inc+2.36+1.95%
SLXPSalix Pharmaceutical...+4.86+3.59%
HSPHospira Inc+0.80+1.55%
RDYDr.Reddy's Laborator...+0.58+1.15%
Data as of 4:07pm ET, 10/24/2014

Financials

Next reporting dateOctober 30, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$354.9M
Annual profit (last year)-$83.1M
Net profit margin-23.43%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Hervé Hoppenot
Chief Financial Officer &
Executive Vice President
David C. Hastings
Corporate headquarters
Wilmington, Delaware

Forecasts